12-21558177-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021957.4(GYS2):​c.1422+23C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.774 in 1,321,506 control chromosomes in the GnomAD database, including 398,444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 40451 hom., cov: 31)
Exomes 𝑓: 0.78 ( 357993 hom. )

Consequence

GYS2
NM_021957.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.56

Publications

10 publications found
Variant links:
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
  • glycogen storage disorder due to hepatic glycogen synthase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 12-21558177-G-C is Benign according to our data. Variant chr12-21558177-G-C is described in ClinVar as Benign. ClinVar VariationId is 261466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYS2NM_021957.4 linkc.1422+23C>G intron_variant Intron 11 of 15 ENST00000261195.3 NP_068776.2 P54840
GYS2XM_024448960.2 linkc.1422+23C>G intron_variant Intron 11 of 16 XP_024304728.1
GYS2XM_006719063.4 linkc.1191+23C>G intron_variant Intron 10 of 14 XP_006719126.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYS2ENST00000261195.3 linkc.1422+23C>G intron_variant Intron 11 of 15 1 NM_021957.4 ENSP00000261195.2 P54840
ENSG00000285854ENST00000647960.1 linkn.*1424+23C>G intron_variant Intron 18 of 22 ENSP00000497202.1 A0A3B3IS95
ENSG00000285854ENST00000648372.1 linkn.1372C>G non_coding_transcript_exon_variant Exon 11 of 11

Frequencies

GnomAD3 genomes
AF:
0.725
AC:
110049
AN:
151870
Hom.:
40414
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.602
Gnomad AMI
AF:
0.633
Gnomad AMR
AF:
0.733
Gnomad ASJ
AF:
0.689
Gnomad EAS
AF:
0.751
Gnomad SAS
AF:
0.797
Gnomad FIN
AF:
0.810
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.782
Gnomad OTH
AF:
0.667
GnomAD2 exomes
AF:
0.765
AC:
191420
AN:
250296
AF XY:
0.767
show subpopulations
Gnomad AFR exome
AF:
0.595
Gnomad AMR exome
AF:
0.785
Gnomad ASJ exome
AF:
0.690
Gnomad EAS exome
AF:
0.750
Gnomad FIN exome
AF:
0.807
Gnomad NFE exome
AF:
0.778
Gnomad OTH exome
AF:
0.731
GnomAD4 exome
AF:
0.781
AC:
913207
AN:
1169518
Hom.:
357993
Cov.:
16
AF XY:
0.781
AC XY:
465427
AN XY:
595964
show subpopulations
African (AFR)
AF:
0.594
AC:
16641
AN:
27994
American (AMR)
AF:
0.780
AC:
34549
AN:
44286
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
16850
AN:
24316
East Asian (EAS)
AF:
0.786
AC:
30090
AN:
38270
South Asian (SAS)
AF:
0.792
AC:
63520
AN:
80252
European-Finnish (FIN)
AF:
0.804
AC:
42846
AN:
53284
Middle Eastern (MID)
AF:
0.633
AC:
3301
AN:
5218
European-Non Finnish (NFE)
AF:
0.790
AC:
667483
AN:
845208
Other (OTH)
AF:
0.748
AC:
37927
AN:
50690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
9733
19466
29200
38933
48666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13926
27852
41778
55704
69630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.725
AC:
110142
AN:
151988
Hom.:
40451
Cov.:
31
AF XY:
0.729
AC XY:
54130
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.602
AC:
24940
AN:
41410
American (AMR)
AF:
0.733
AC:
11202
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.689
AC:
2388
AN:
3468
East Asian (EAS)
AF:
0.751
AC:
3870
AN:
5152
South Asian (SAS)
AF:
0.795
AC:
3828
AN:
4814
European-Finnish (FIN)
AF:
0.810
AC:
8550
AN:
10558
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.782
AC:
53197
AN:
67998
Other (OTH)
AF:
0.669
AC:
1410
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1483
2967
4450
5934
7417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
844
1688
2532
3376
4220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.696
Hom.:
3926
Bravo
AF:
0.711
Asia WGS
AF:
0.751
AC:
2606
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 23, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.61
DANN
Benign
0.30
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7977474; hg19: chr12-21711111; API